×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Worldwide schedules comment Share
8154 views

Animateurs:

  • Dr Gwenaël Ferron, chirurgien oncologue Institut Universitaire du Cancer Toulouse
  • Coralie Marjollet, Imagyn

La Société Française de Chirurgie Oncologique s’associe à l’association IMAGYN pour un webinar ONCOSTREAM sur les Tumeurs Rares de l'Ovaire à destination des patientes et des professionnels de santé.

Quelques exemples des thèmes qui seront abordés lors de cette réunion interactive entre oncologues experts du groupe GINECO, spécialistes de soins de support et les patientes :

  • Qu'est-ce qu'une tumeur rare de l'ovaire ?
  • Pourquoi cela touche des femmes jeunes voire des adolescentes ?
  • Quels sont les traitements proposés et pourquoi ?
  • Comment prévenir et prendre en charge les séquelles de traitements, en particulier la fertilité, la ménopause, la sexualité ?
  • Comment accompagner au mieux les patientes et leurs familles? Place de l'association de patientes IMAGYN
  • Quel est le rôle du réseau de centres experts TMRO ?

Afin de pouvoir poser vos questions en direct aux intervenants un chat sera mis à votre disposition.

Shooting date : 2021-05-10
Last update : 2024-02-13
1 comment
Join the Discussion
  • Lauriane G. merci pour la presentation

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Tuesday, June 18th 2024 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, June 18th 2024 from 06am to 07:30am (GMT+2)
    San Francisco : Tuesday, June 18th 2024 from 09am to 10:30am (GMT+2)
    New York : Tuesday, June 18th 2024 from 12pm to 01:30pm (GMT+2)
    Buenos Aires : Tuesday, June 18th 2024 from 01pm to 02:30pm (GMT+2)
    Reykjavik : Tuesday, June 18th 2024 from 04pm to 05:30pm (GMT+2)
    London / Dublin : Tuesday, June 18th 2024 from 05pm to 06:30pm (GMT+2)
    Paris / Berlin : Tuesday, June 18th 2024 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, June 18th 2024 from 07pm to 08:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, June 18th 2024 from 08pm to 09:30pm (GMT+2)
    Bangkok : Tuesday, June 18th 2024 from 11pm to 12:30am (GMT+2)
    Shanghai : Wednesday, June 19th 2024 from 12am to 01:30am (GMT+2)
    Tokyo : Wednesday, June 19th 2024 from 01am to 02:30am (GMT+2)
    Sydney : Wednesday, June 19th 2024 from 03am to 04:30am (GMT+2)
    Wellington : Wednesday, June 19th 2024 from 05am to 06:30am (GMT+2)

    La qualité de vie

    et le cancer de l'ovaire

    Share
    Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
    Honolulu : Wednesday, January 22nd 2025 from 06am to 07am (GMT+1)
    San Francisco : Wednesday, January 22nd 2025 from 08am to 09am (GMT+1)
    New York : Wednesday, January 22nd 2025 from 11am to 12pm (GMT+1)
    Buenos Aires : Wednesday, January 22nd 2025 from 01pm to 02pm (GMT+1)
    London / Dublin : Wednesday, January 22nd 2025 from 04pm to 05pm (GMT+1)
    Paris / Berlin : Wednesday, January 22nd 2025 from 05pm to 06pm (GMT+1)
    Istanbul : Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
    Moscou / Dubaï : Wednesday, January 22nd 2025 from 08pm to 09pm (GMT+1)
    Bangkok : Wednesday, January 22nd 2025 from 11pm to 12am (GMT+1)
    Shanghai : Thursday, January 23rd 2025 from 12am to 01am (GMT+1)
    Tokyo : Thursday, January 23rd 2025 from 01am to 02am (GMT+1)
    Sydney : Thursday, January 23rd 2025 from 02am to 03am (GMT+1)
    Wellington : Thursday, January 23rd 2025 from 04am to 05am (GMT+1)

    Prise en charge des cancers de l'ovaire en rechute :

    état des lieux et perspectives

    Share
    Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Honolulu : Tuesday, September 5th 2023 from 06:30am to 08am (GMT+2)
    San Francisco : Tuesday, September 5th 2023 from 09:30am to 11am (GMT+2)
    New York : Tuesday, September 5th 2023 from 12:30pm to 02pm (GMT+2)
    Buenos Aires : Tuesday, September 5th 2023 from 01:30pm to 03pm (GMT+2)
    Reykjavik : Tuesday, September 5th 2023 from 04:30pm to 06pm (GMT+2)
    London / Dublin : Tuesday, September 5th 2023 from 05:30pm to 07pm (GMT+2)
    Paris / Berlin : Tuesday, September 5th 2023 from 06:30pm to 08pm (GMT+2)
    Istanbul : Tuesday, September 5th 2023 from 07:30pm to 09pm (GMT+2)
    Moscou / Dubaï : Tuesday, September 5th 2023 from 08:30pm to 10pm (GMT+2)
    Bangkok : Tuesday, September 5th 2023 from 11:30pm to 01am (GMT+2)
    Shanghai : Wednesday, September 6th 2023 from 12:30am to 02am (GMT+2)
    Tokyo : Wednesday, September 6th 2023 from 01:30am to 03am (GMT+2)
    Sydney : Wednesday, September 6th 2023 from 03:30am to 05am (GMT+2)
    Wellington : Wednesday, September 6th 2023 from 05:30am to 07am (GMT+2)

    Les nouveaux enjeux de la prise en charge du cancer de l’ovaire en première ligne : L’exemple d...

    Cycle d'enseignement sur le cancer de l'ovaire - Première session

    Share
    Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
    Honolulu : Wednesday, March 20th 2024 from 07am to 08am (GMT+1)
    San Francisco : Wednesday, March 20th 2024 from 09am to 10am (GMT+1)
    New York : Wednesday, March 20th 2024 from 12pm to 01pm (GMT+1)
    Buenos Aires : Wednesday, March 20th 2024 from 02pm to 03pm (GMT+1)
    London / Dublin : Wednesday, March 20th 2024 from 05pm to 06pm (GMT+1)
    Paris / Berlin : Wednesday, March 20th 2024 from 06pm to 07pm (GMT+1)
    Istanbul : Wednesday, March 20th 2024 from 07pm to 08pm (GMT+1)
    Moscou / Dubaï : Wednesday, March 20th 2024 from 09pm to 10pm (GMT+1)
    Bangkok : Thursday, March 21st 2024 from 12am to 01am (GMT+1)
    Shanghai : Thursday, March 21st 2024 from 01am to 02am (GMT+1)
    Tokyo : Thursday, March 21st 2024 from 02am to 03am (GMT+1)
    Sydney : Thursday, March 21st 2024 from 03am to 04am (GMT+1)
    Wellington : Thursday, March 21st 2024 from 05am to 06am (GMT+1)

    Immunothérapies et inhibiteurs de PARP dans la prise en charge du cancer de l’endomètre avancé ...

    éclairages du congrès de la SGO

    Share
    Scroll Up